• Explore /
  • Poster
  • / Activity of pazopanib in chemo-resistant patients with germ cell tumors (GCT): First results of the open-label, single-group, phase II PAZOTEST-01 trial.

Activity of pazopanib in chemo-resistant patients with germ cell tumors (GCT): First results of the open-label, single-group, phase II PAZOTEST-01 trial.

Abstract Poster

Authors

null

Patrizia Giannatempo

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

Patrizia Giannatempo , Nicola Nicolai , Elena Farè , Daniele Raggi , Luigi Piva , Davide Biasoni , Mario Catanzaro , Tullio Torelli , Silvia Stagni , Massimo Maffezzini , Alessandro Crestani , Elena Togliardi , Roberto Salvioni , Alessandro M. Gianni , Andrea Necchi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session B: Prostate, Penile, Urethral, and Testicular Cancers, and Urothelial Carcinoma

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers

Sub Track

Penile, Urethral, and Testicular Cancers

Clinical Trial Registration Number

NCT01743482

Citation

J Clin Oncol 32, 2014 (suppl 4; abstr 376)

DOI

10.1200/jco.2014.32.4_suppl.376

Abstract #

376

Poster Bd #

L1

Abstract Disclosures

Similar Posters

First Author: Andrea Necchi

First Author: Andrea Necchi

First Author: Andrea Necchi

First Author: Ugo De Giorgi